Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 185

Sort by

Sort Order Select

Journal Articles

CMV reactivation under foscarnet prophylaxis in cord blood transplantation: Increased NRM without impact on relapse or survival

Shogo Matsui, Hisashi Yamamoto, Mika Kuno, Otoya Watanabe, Kyosuke Yamaguchi, Kosei Kageyama, Daisuke Kaji, Yuki Taya, Aya Nishida, Kazuya Ishiwata, Shinsuke Takagi, Yuki Asano-Mori, Go Yamamoto, Atsushi Wake, Shuichi Taniguchi, Naoyuki Uchida

Blood (2025) 146 (Supplement 1): 7787.

https://doi.org/10.1182/blood-2025-7787

Published: 2025

Journal Articles

Clinical and microbiological insights into invasive fusariosis following allogeneic hematopoietic stem cell transplantation: A 15-year single-center analysis

Blood (2025) 146 (Supplement 1): 2492.

https://doi.org/10.1182/blood-2025-2492

Published: 2025

Journal Articles

Clinical characteristics and whole-exome sequencing-based genomic profiling of post-transplant lymphoproliferative disorders following allogeneic hematopoietic stem cell transplantation

Tatsuro Hirao, Daisuke Kaji, Yuki Shimizu, Kenichi Makishima, Mamiko Sakata-Yanagimoto, Mika Kuno, Otoya Watanabe, Kyosuke Yamaguchi, Kosei Kageyama, Yuki Taya, Aya Nishida, Shinsuke Takagi, Hisashi Yamamoto, Yuki Asano-Mori, Go Yamamoto, Atsushi Wake, Naoyuki Uchida

Blood (2025) 146 (Supplement 1): 1760.

https://doi.org/10.1182/blood-2025-1760

Published: 2025

Journal Articles

Novel prognostic scoring system for hematopoietic stem cell transplantation in myelodysplastic syndrome and Acute Myeloid Leukemia, myelodysplasia-related

Shunsuke Nishino, Hisashi Yamamoto, Go Yamamoto, Mika Kuno, Otoya Watanabe, Kyosuke Yamaguchi, Kosei Kageyama, Daisuke Kaji, Yuki Taya, Aya Nishida, Kazuya Ishiwata, Shinsuke Takagi, Yuki Asano-Mori, Atsushi Wake, Shuichi Taniguchi, Naoyuki Uchida

Blood (2025) 146 (Supplement 1): 7829.

https://doi.org/10.1182/blood-2025-7829

Published: 2025

Journal Articles

Outcomes of umbilical cord blood transplantation for acute myeloid leukemia in the era of FLT3 inhibitors.

Aya Nishida, Mika Kuno, Otoya Watanabe, Kyousuke Yamaguchi, Kosei Kageyama, Daisuke Kaji, Yuki Taya, Shinsuke Takagi, Hisashi Yamamoto, Go Yamamoto, Yuki Asano-Mori, Atsushi Wake, Shuichi Taniguchi, Naoyuki Uchida

Blood (2025) 146 (Supplement 1): 7827.

https://doi.org/10.1182/blood-2025-7827

Published: 2025

Journal Articles

A single-institution retrospective analysis of allo-HSCT for relapsed and refractory aggressive lymphomas: T-cell origin predicts better outcomes even in active disease.

Futoshi Yoshino, Daisuke Kaji, Mika Kuno, Otoya Watanabe, Kyosuke Yamaguchi, Kosei Kageyama, Yuki Taya, Aya Nishida, Shinsuke Takagi, Hisashi Yamamoto, Yuki Asano-Mori, Atsushi Wake, Naoyuki Uchida, Go Yamamoto

Blood (2025) 146 (Supplement 1): 7822.

https://doi.org/10.1182/blood-2025-7822

Published: 2025

Journal Articles

A simple, 3-factor pre-treatment score (Toranomon Prognostic Score) robustly stratifies progression risk in patients with relapsed/refractory large B-cell lymphoma receiving commercial CAR T-cell therapy: A real-world analysis

Rikako Tabata, Daisuke Kaji, Go Yamamoto, Mika Kuno, Otoya Watanabe, Kyosuke Yamaguchi, Kosei Kageyama, Yuki Taya, Aya Nishida, Kazuya Ishiwata, Shinsuke Takagi, Hisashi Yamamoto, Yuki Asano-Mori, Atsushi Wake, Shuichi Taniguchi, Naoyuki Uchida

Blood (2025) 146 (Supplement 1): 1942.

https://doi.org/10.1182/blood-2025-1942

Published: 2025

Journal Articles

Clinical characteristics of human herpesvirus 7 (HHV-7) reactivation following umbilical cord blood transplantation: A retrospective study

Kai Ishimaru, Shinsuke Takagi, Mika Kuno, Otoya Watanabe, Kyosuke Yamaguchi, Kosei Kageyama, Daisuke Kaji, Aya Nishida, Yuki Taya, Kazuya Ishiwata, Hisashi Yamamoto, Yuki Asano-Mori, Go Yamamoto, Atsushi Wake, Shuichi Taniguchi, Naoyuki Uchida

Blood (2025) 146 (Supplement 1): 4195.

https://doi.org/10.1182/blood-2025-4195

Published: 2025

Journal Articles

Differential trends in survival after allogeneic transplantation for MDS and MDS/MPN in a real-world experience

Blood (2025) 146 (Supplement 1): 3843.

https://doi.org/10.1182/blood-2025-3843

Published: 2025

Journal Articles

Real-world experience with ruxolitinib therapy for steroid-refractory acute graft-versus-host disease following umbilical cord blood transplantation

Mika Kuno, Hisashi Yamamoto, Otoya Watanabe, Kyosuke Yamaguchi, Kosei Kageyama, Daisuke Kaji, Yuki Taya, Aya Nishida, Kazuya Ishiwata, Shinsuke Takagi, Yuki Asano-Mori, Go Yamamoto, Atsushi Wake, Shuichi Taniguchi, Naoyuki Uchida

Blood (2025) 146 (Supplement 1): 7757.

https://doi.org/10.1182/blood-2025-7757

Published: 2025

Journal Articles

The limited impact of preexisting rheumatologic diseases on outcomes after allogeneic hematopoietic stem cell transplantation: A nationwide Propensity–Matched analysis

Noirna Tanaka, Akihito Shinohara, Shun-Ichi Kimura, Shinichi Kobayashi, Naoyuki Uchida, Noboru Asada, Shuichi Ota, Masatsugu Tanaka, Yasuyuki Arai, Keisuke Kataoka, Maki Hagihara, Makoto Onizuka, Yukinori Nakamura, Ken-ichi Matsuoka, Koji Kawamura, Junya Kanda, Takahiro Fukuda, Yoshiko Atsuta, Hideki Nakasone

Blood (2025) 146 (Supplement 1): 6051.

https://doi.org/10.1182/blood-2025-6051

Published: 2025

Journal Articles

Low serum IgG at apheresis predicts delayed humoral immune reconstitution and increased risk of infections after CD19 CAR T-cell therapy for B-cell lymphoma

Daisuke Kaji, Tatsuro Hirao, Mika Kuno, Otoya Watanabe, Kyosuke Yamaguchi, Kosei Kageyama, Yuki Taya, Aya Nishida, Shinsuke Takagi, Hisashi Yamamoto, Yuki Asano-Mori, Atsushi Wake, Naoyuki Uchida, Go Yamamoto

Blood (2025) 146 (Supplement 1): 5492.

https://doi.org/10.1182/blood-2025-5492

Published: 2025

Journal Articles

Temporal trends in treatment outcomes of acute lymphoblastic leukemia in Japan: Progress and unmet needs

Ryo Koizumi, Aya Nishida, Mika Kuno, Otoya Watanabe, Kyosuke Yamaguchi, Kosei Kageyama, Daisuke Kaji, Yuki Taya, Kazuya Ishiwata, Shinsuke Takagi, Hisashi Yamamoto, Yuki Asano-Mori, Go Yamamoto, Atsushi Wake, Shuichi Taniguchi, Naoyuki Uchida

Blood (2025) 146 (Supplement 1): 1553.

https://doi.org/10.1182/blood-2025-1553

Published: 2025

Journal Articles

Efficacy of upfront blinatumomab combined with reduced-intensity chemotherapy for newly diagnosed adult Philadelphia chromosome–negative B-lineage acute lymphoblastic leukemia: Interim analysis of two prospective studies of JSCT ALL/MRD2023 and ALL/MRD2019 in Japan

Blood (2025) 146 (Supplement 1): 5116.

https://doi.org/10.1182/blood-2025-5116

Published: 2025

Journal Articles

Single-unit cord blood transplantation reduces the risk of relapse and improves leukemia-free survival compared to other donor sources in allo-HSCT for patients with high-risk acute myeloid leukemia

Tatsuro Hirao, Hisashi Yamamoto, Mika Kuno, Otoya Watanabe, Kyosuke Yamaguchi, Kosei Kageyama, Daisuke Kaji, Yuki Taya, Aya Nishida, Shinsuke Takagi, Yuki Asano-Mori, Go Yamamoto, Atsushi Wake, Naoyuki Uchida

Blood (2025) 146 (Supplement 1): 591.

https://doi.org/10.1182/blood-2025-591

Published: 2025

Journal Articles

Tailoring TBI for vulnerable patients: 8 gy TBI shows comparable outcomes to 12 gy TBI in adult ALL allo-HSCT

Tomoyo Kubo, Shinsuke Takagi, Mika Kuno, Otoya Watanabe, Kyosuke Yamaguchi, Kosei Kageyama, Aya Nishida, Daisuke Kaji, Yuki Taya, Kazuya Ishiwata, Hisashi Yamamoto, Atsushi Wake, Yuki Asano-Mori, Go Yamamoto, Shuichi Taniguchi, Naoyuki Uchida

Blood (2025) 146 (Supplement 1): 5971.

https://doi.org/10.1182/blood-2025-5971

Published: 2025

Journal Articles

Allogeneic Hematopoietic Cell Transplantation for Patients with Relapsed or Refractory Diffuse Large B Cell Lymphoma with Stable or Progressive Disease

Kimimori Kamijo, Yoshimitsu Shimomura, Naoyuki Uchida, Satoshi Yoshihara, Takahiro Fukuda, Yasufumi Uehara, Yasuo Mori, Tetsuya Eto, Hikaru Kobayashi, Kentaro Serizawa, Tatsuo Ichinohe, Makoto Yoshimitsu, Junya Kanda, Yoshiko Atsuta, Shinichi Kako

Blood (2024) 144 (Supplement 1): 2166.

https://doi.org/10.1182/blood-2024-206578

Published: 2024

Journal Articles

Allogeneic Hematopoietic Cell Transplantation in Adult Acute Myeloid Leukemia with t(16;21)(p11;q22)

Satoshi Mitsuyuki, Yoshimitsu Shimomura, Hiroki Mizumaki, Masamitsu Yanada, Shohei Mizuno, Naoyuki Uchida, Noriko Doki, Ayumu Ito, Masatsugu Tanaka, Tetsuya Nishida, Yuta Katayama, Satoshi Yoshihara, Tetsuya Eto, Koji Kawamura, Makoto Onizuka, Takahiro Fukuda, Marie Ohbiki, Yoshiko Atsuta, Takaaki Konuma

Blood (2024) 144 (Supplement 1): 1469.

https://doi.org/10.1182/blood-2024-198750

Published: 2024

Journal Articles

Retrospective Analysis of Single-Unit Umbilical Cord Blood Transplantation in Elderly Patients (Aged 65 Years and Older) with Predominantly High-Risk Myeloid Malignancies: A Single-Institution Study

Yuki Taya, Mika Kuno, Otoya Watanabe, Kyosuke Yamaguchi, Kosei Kageyama, Daisuke Kaji, Aya Nishida, Kazuya Ishiwata, Shinsuke Takagi, Hisashi Yamamoto, Go Yamamoto, Yuki Asano-Mori, Atsushi Wake, Naoyuki Uchida

Blood (2024) 144 (Supplement 1): 7437.

https://doi.org/10.1182/blood-2024-208778

Published: 2024

Journal Articles

Novel Insights into Predictors, Optimized Treatments, and Prognosis Factors for Virus-Induced Hemorrhagic Cystitis Post-Hematopoietic Stem Cell Transplantation: A Single-Institution Study of 427 Japanese Patients

Michikata Hayashida, Aya Nishida, Mika Kuno, Otoya Watanabe, Daisuke Kaji, Yuki Taya, Shinsuke Takagi, Hisashi Yamamoto, Go Yamamoto, Suguru Oka, Kazushige Sakaguchi, Shinji Urakami, Naoyuki Uchida

Blood (2024) 144 (Supplement 1): 2162.

https://doi.org/10.1182/blood-2024-199936

Published: 2024

Update search

NARROW

Publications

Format

Subjects

Article Type

Topics

Date

Availability

CMV reactivation under foscarnet prophylaxis in cord blood transplantation: Increased NRM without impact on relapse or survival

Clinical and microbiological insights into invasive fusariosis following allogeneic hematopoietic stem cell transplantation: A 15-year single-center analysis

Clinical characteristics and whole-exome sequencing-based genomic profiling of post-transplant lymphoproliferative disorders following allogeneic hematopoietic stem cell transplantation

Novel prognostic scoring system for hematopoietic stem cell transplantation in myelodysplastic syndrome and Acute Myeloid Leukemia, myelodysplasia-related

Outcomes of umbilical cord blood transplantation for acute myeloid leukemia in the era of FLT3 inhibitors.

A single-institution retrospective analysis of allo-HSCT for relapsed and refractory aggressive lymphomas: T-cell origin predicts better outcomes even in active disease.

A simple, 3-factor pre-treatment score (Toranomon Prognostic Score) robustly stratifies progression risk in patients with relapsed/refractory large B-cell lymphoma receiving commercial CAR T-cell therapy: A real-world analysis

Clinical characteristics of human herpesvirus 7 (HHV-7) reactivation following umbilical cord blood transplantation: A retrospective study

Differential trends in survival after allogeneic transplantation for MDS and MDS/MPN in a real-world experience

Real-world experience with ruxolitinib therapy for steroid-refractory acute graft-versus-host disease following umbilical cord blood transplantation

The limited impact of preexisting rheumatologic diseases on outcomes after allogeneic hematopoietic stem cell transplantation: A nationwide Propensity–Matched analysis

Low serum IgG at apheresis predicts delayed humoral immune reconstitution and increased risk of infections after CD19 CAR T-cell therapy for B-cell lymphoma

Temporal trends in treatment outcomes of acute lymphoblastic leukemia in Japan: Progress and unmet needs

Efficacy of upfront blinatumomab combined with reduced-intensity chemotherapy for newly diagnosed adult Philadelphia chromosome–negative B-lineage acute lymphoblastic leukemia: Interim analysis of two prospective studies of JSCT ALL/MRD2023 and ALL/MRD2019 in Japan

Single-unit cord blood transplantation reduces the risk of relapse and improves leukemia-free survival compared to other donor sources in allo-HSCT for patients with high-risk acute myeloid leukemia

Tailoring TBI for vulnerable patients: 8 gy TBI shows comparable outcomes to 12 gy TBI in adult ALL allo-HSCT

Allogeneic Hematopoietic Cell Transplantation for Patients with Relapsed or Refractory Diffuse Large B Cell Lymphoma with Stable or Progressive Disease

Allogeneic Hematopoietic Cell Transplantation in Adult Acute Myeloid Leukemia with t(16;21)(p11;q22)

Retrospective Analysis of Single-Unit Umbilical Cord Blood Transplantation in Elderly Patients (Aged 65 Years and Older) with Predominantly High-Risk Myeloid Malignancies: A Single-Institution Study

Novel Insights into Predictors, Optimized Treatments, and Prognosis Factors for Virus-Induced Hemorrhagic Cystitis Post-Hematopoietic Stem Cell Transplantation: A Single-Institution Study of 427 Japanese Patients

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only